These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

277 related items for PubMed ID: 8994216

  • 1. Selective blockade of peripheral delta opioid agonist induced antinociception by intrathecal administration of delta receptor antisense oligodeoxynucleotide.
    Bilsky EJ, Wang T, Lai J, Porreca F.
    Neurosci Lett; 1996 Dec 20; 220(3):155-8. PubMed ID: 8994216
    [Abstract] [Full Text] [Related]

  • 2. Characterization of antinociception to opioid receptor selective agonists after antisense oligodeoxynucleotide-mediated "knock-down" of opioid receptor in vivo.
    Bilsky EJ, Bernstein RN, Hruby VJ, Rothman RB, Lai J, Porreca F.
    J Pharmacol Exp Ther; 1996 Apr 20; 277(1):491-501. PubMed ID: 8613959
    [Abstract] [Full Text] [Related]

  • 3. Selective inhibition of [D-Ala2, Glu4]deltorphin antinociception by supraspinal, but not spinal, administration of an antisense oligodeoxynucleotide to an opioid delta receptor.
    Bilsky EJ, Bernstein RN, Pasternak GW, Hruby VJ, Patel D, Porreca F, Lai J.
    Life Sci; 1994 Apr 20; 55(2):PL37-43. PubMed ID: 8015351
    [Abstract] [Full Text] [Related]

  • 4. Interaction between the mu-agonist dermorphin and the delta-agonist [D-Ala2, Glu4]deltorphin in supraspinal antinociception and delta-opioid receptor binding.
    Negri L, Improta G, Lattanzi R, Potenza RL, Luchetti F, Melchiorri P.
    Br J Pharmacol; 1995 Dec 20; 116(7):2931-8. PubMed ID: 8680727
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. The effect of pretreatment with a delta 2-opioid receptor antisense oligodeoxynucleotide on the recovery from acute antinociceptive tolerance to delta 2-opioid receptor agonist in the mouse spinal cord.
    Narita M, Mizoguchi H, Kampine JP, Tseng LF.
    Br J Pharmacol; 1997 Feb 20; 120(4):587-92. PubMed ID: 9051295
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Differential effects of intrathecally administered delta and mu opioid receptor agonists on formalin-evoked nociception and on the expression of Fos-like immunoreactivity in the spinal cord of the rat.
    Hammond DL, Wang H, Nakashima N, Basbaum AI.
    J Pharmacol Exp Ther; 1998 Jan 20; 284(1):378-87. PubMed ID: 9435201
    [Abstract] [Full Text] [Related]

  • 12. Differential effects of antisense oligodeoxynucleotides directed against g(zalpha) and g(oalpha) on antinociception produced by spinal opioid and alpha(2) adrenergic receptor agonists.
    Karim F, Roerig SC.
    Pain; 2000 Aug 20; 87(2):181-191. PubMed ID: 10924811
    [Abstract] [Full Text] [Related]

  • 13. In vivo injection of antisense oligodeoxynucleotides to G alpha subunits and supraspinal analgesia evoked by mu and delta opioid agonists.
    Sánchez-Blázquez P, García-España A, Garzón J.
    J Pharmacol Exp Ther; 1995 Dec 20; 275(3):1590-6. PubMed ID: 8531133
    [Abstract] [Full Text] [Related]

  • 14. Selective attenuation of mu-opioid receptor-mediated effects in rat sensory neurons by intrathecal administration of antisense oligodeoxynucleotides.
    Khasar SG, Gold MS, Dastmalchi S, Levine JD.
    Neurosci Lett; 1996 Oct 25; 218(1):17-20. PubMed ID: 8939470
    [Abstract] [Full Text] [Related]

  • 15. Morphine can produce analgesia via spinal kappa opioid receptors in the absence of mu opioid receptors.
    Yamada H, Shimoyama N, Sora I, Uhl GR, Fukuda Y, Moriya H, Shimoyama M.
    Brain Res; 2006 Apr 14; 1083(1):61-9. PubMed ID: 16530171
    [Abstract] [Full Text] [Related]

  • 16. Effect of supraspinal antisense oligodeoxynucleotide treatment on delta-opioid receptor mRNA levels in mice.
    Lee CE, Kest B, Jenab S, Inturrisi CE.
    Brain Res Mol Brain Res; 1997 Aug 14; 48(1):17-22. PubMed ID: 9379841
    [Abstract] [Full Text] [Related]

  • 17. Role of protein kinase C in desensitization of spinal delta-opioid-mediated antinociception in the mouse.
    Narita M, Mizoguchi H, Kampine JP, Tseng LF.
    Br J Pharmacol; 1996 Aug 14; 118(7):1829-35. PubMed ID: 8842450
    [Abstract] [Full Text] [Related]

  • 18. An antisense oligodeoxynucleotide to mu-opioid receptors inhibits mu-opioid receptor agonist-induced analgesia in rats.
    Chen XH, Adams JU, Geller EB, DeRiel JK, Adler MW, Liu-Chen LY.
    Eur J Pharmacol; 1995 Feb 24; 275(1):105-8. PubMed ID: 7774656
    [Abstract] [Full Text] [Related]

  • 19. Antisense oligodeoxynucleotide to a delta-opioid receptor blocks the antinociception induced by cold water swimming.
    Mizoguchi H, Narita M, Nagase H, Tseng LF.
    Regul Pept; 1995 Oct 20; 59(2):255-9. PubMed ID: 8584762
    [Abstract] [Full Text] [Related]

  • 20. Spinal pretreatment with antisense oligodeoxynucleotides against exon-1, -4, or -8 of mu-opioid receptor clone leads to differential loss of spinal endomorphin-1-and endomorphin-2-induced antinociception in the mouse.
    Wu HE, Mizoguchi H, Terashvili M, Leitermann RJ, Hung KC, Fujimoto JM, Tseng LF.
    J Pharmacol Exp Ther; 2002 Nov 20; 303(2):867-73. PubMed ID: 12388674
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.